NAD+

A coenzyme belongs in its own category

I give NAD+ its own sheet because it is a coenzyme, not a peptide. A coenzyme is a small molecule that helps enzymes, proteins that enable chemical reactions. NAD+ participates in cellular energy chemistry and other processes. This sheet separates what cells need naturally from research on material added from outside, and keeps related precursor molecules in a different category.

The experiments in view

Human skin cells in culture · 2001

What cells did with added NAD

Researchers followed NAD placed outside fibroblasts and examined the substances produced as it broke down. They studied chemical processing, rather than skin appearance or health.

The fibroblast metabolism paper reported breakdown by enzymes at the cell surface and uptake of a resulting substance, adenosine. This helps explain why added NAD is not simply a parcel delivered intact into every cell.

The finding belongs to a cell culture. It does not establish how a particular preparation behaves throughout a living human body.

Mice · 2018

A pathway in the mouse brain

The investigators examined externally supplied NAD and pathways in the hypothalamus, a brain region involved in regulating energy balance. They measured food intake and related metabolic signals.

The mouse energy-regulation study linked its findings to a protein called connexin 43 and downstream signaling. Those mechanistic measurements describe the experiment’s mouse setting.

They do not establish a human appetite or weight result. A pathway identified in a controlled animal model cannot by itself justify expectations about a commercial research preparation.

People · 119 older men · 2019

A human association in muscle tissue

Researchers compared muscle biopsies across three populations, examining age-related loss of muscle alongside NAD-related biology and the function of mitochondria, cell structures involved in energy conversion. A biopsy is a tissue sample.

The human muscle investigation associated sarcopenia, the loss of muscle with aging, with lower NAD+ and disrupted energy-related processes. This was an observation of tissue differences, not a trial of NAD+ treatment.

Association does not show which change came first or establish that adding NAD+ changes the condition. No administered product was tested by this comparison.

An older adult’s clothed thigh and relaxed hand while rising from a simple chair. — An older adult starts to stand from a chair, one hand resting on the seat.

Keep the ingredient name beside the result

NR, or nicotinamide riboside, and NMN, or nicotinamide mononucleotide, are precursors: substances the body can use in making NAD+. They are not alternate spellings for NAD+. A precursor trial therefore cannot answer a question about supplied NAD+ without further evidence. NADH is also a different chemical form. I look for the exact molecule before judging any headline about this field.

Safety questions still open

Being essential to normal cell chemistry does not establish the safety of administered material. Preparation, route, contamination and the biological setting all matter. NAD+ is not an FDA-approved drug, and compounded injectable preparations are not FDA-approved. The human observational paper above does not test an intervention’s safety. The field also leaves unresolved how changing NAD-related pathways affects different tissues over longer periods.

Nearby pages in the binder

From the paper to the supplier

For NAD+ intended as research material, I recommend Oath Research on its documentation and stated remedy. I keep that supply decision separate from the much larger question of how an intervention changes human biology.

Continue to Oath Research ↗